Provided By GlobeNewswire
Last update: Oct 29, 2025
WARREN, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), in ongoing community, industry, and academic engagements, has continued to underscore its biopharma model centered on sustainability and patient affordability, highlighting the Company’s significant progress toward making precision medicine accessible to all.
Read more at globenewswire.comNASDAQ:TVGNW (11/10/2025, 2:37:53 PM)
0.0491
0 (-0.61%)
NASDAQ:TVGN (11/10/2025, 2:35:03 PM)
0.4774
-0.02 (-4.35%)
Find more stocks in the Stock Screener


